Zengqiang Qu
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus.
Journal: Journal of hepatocellular carcinoma
Published: September 24, 2024
Vascular stent graft for the treatment of post-pancreaticoduodenectomy hemorrhage and risk factors for rebleeding.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 27, 2024
Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World.
Journal: Frontiers in oncology
Published: May 22, 2022
Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study.
Journal: Journal of gastrointestinal oncology
Published: March 31, 2022
Coexistence of situs inversus totalis and hepatocellular carcinoma: A series of nine cases and a literature review.
Journal: Journal of interventional medicine
Published: November 22, 2021
In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes.
Journal: BMC complementary medicine and therapies
Published: January 12, 2021
Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics.
Journal: Bioorganic & medicinal chemistry letters
Published: November 02, 2020
Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study.
Journal: Hepatology international
Published: November 02, 2020
miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
Journal: Biochemical and biophysical research communications
Published: June 12, 2015
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2015
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.
Journal: Cell research
Published: August 18, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026